For more information

on this study please

call +1 877-379-3718

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.

Study ID

208129/037

Study Title Evaluating the consistency of 3 consecutive lots of GSK Bio's novel adjuvanted HBV vaccine with single-blind safety evaluation using Engerix™-B as a control, administered according to a 0, 1, 2-mth schedule in healthy volunteers (15-50y).
Clinicaltrials.gov Identifier NCT00697866
Sponsor GlaxoSmithKline
Collaborators N/A
Study Recruitment Status Completed
Generic Name Hepatitis B Vaccine, Recombinant
Trade Name Engerix-B
Study Indication Hepatitis B